← Open Payments lookup

LIDIA TIMOFEENKO PETERSEN: Open Payments

NPI 1245857952 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,857 in 91 payments from 9 companies in 2025. Trend: 2023 $1,182 · 2024 $1,831 · 2025 $2,857

Food & beverage: $2,045Consulting: $812
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.7$933
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$452
Neurocrine BioSciences, Inc.17$433
Alkermes, Inc.14$301
E.R. Squibb & Sons, L.L.C.14$279
Teva Pharmaceuticals USA, Inc.11$170
ABBVIE INC.7$145
Janssen Pharmaceuticals, Inc7$122
Vanda Pharmaceuticals Inc.1$21

Products named: ABILIFY MAINTENA, CAPLYTA, INGREZZA, ARISTADA, COBENFY, VRAYLAR, INVEGA SUSTENNA, REXULTI.

Industry payments across NV — which companies pay providers there.